Galera Therapeutics, Inc.
GRTXDelisted Sep 6, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001563577
Galera Therapeutics, Inc. was delisted on Sep 6, 2024; its insiders filed their last Form 4 on Aug 5, 2026; 36 institutions reported holding it in 13F filings for Q1 2024, worth $1.37M in total; no superinvestor held it.
13F holders, Q2 2022
Institutional positions in Galera Therapeutics, Inc. as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 39
- −7 vs. Q1 2022
- Shares held
- 10.5M
- −734.4K (−6.5%) vs. Q1 2022
- Total value
- $13.7M
- −$13.1M (−48.9%) vs. Q1 2022
- New holders
- 2
- 5 more added
- Sold out
- 9
- 18 more reduced
1 institution that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting GRTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 1 | $4 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 1 | $7.13K |
| Q1 2024 | 36 | $1.37M |
| Q4 2023 | 37 | $1.88M |
| Q3 2023 | 38 | $1.53M |
| Q2 2023 | 55 | $57.8M |
| Q1 2023 | 40 | $47.8M |
| Q4 2022 | 32 | $17.9M |
| Q3 2022 | 33 | $18.1M |
| Q2 2022 | 39 | $13.7M |
| Q1 2022 | 47 | $26.9M |
| Q4 2021 | 44 | $50.6M |
| Q3 2021 | 40 | $161.8M |
| Q2 2021 | 47 | $201.5M |
| Q1 2021 | 54 | $168.5M |
Institutions, Q2 2022
Shares, value and share of portfolio for each institution holding Galera Therapeutics, Inc.; share changes are against Q1 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| JPMorgan Chase & Co | 24 | $0 | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 107 | $0 | 0.00% | 00.0% | Unchanged |
| Captrust Financial Advisors | 1,000 | $1.00K | 0.00% | 00.0% | Unchanged |
| FNY Investment Advisers, LLC | 1,500 | $1.00K | 0.00% | +1,500 | New |
| Simplex Trading, LLC | 1,729 | $2.00K | 0.00% | −16,834−90.7% | Reduced |
| Cutler Group LP | 1,600 | $2.00K | 0.00% | −100−5.9% | Reduced |
| Federation des caisses Desjardins du Quebec | 2,100 | $2.73K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 2,919 | $3.00K | 0.00% | −1,907−39.5% | Reduced |
| Wells Fargo & Company | 2,063 | $3.00K | 0.00% | +6+0.3% | Added |
| US Bancorp | 3,383 | $4.00K | 0.00% | +2,000+144.6% | Added |
| Morgan Stanley | 4,107 | $6.00K | 0.00% | −1,441−26.0% | Reduced |
| TCI Wealth Advisors, Inc. | 6,162 | $8.00K | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 9,210 | $12.0K | 0.00% | −43−0.5% | Reduced |
| Taylor Wealth Management Partners | 10,700 | $14.0K | 0.01% | −935−8.0% | Reduced |
| Goldman Sachs Group Inc | 11,637 | $15.0K | 0.00% | −4,201−26.5% | Reduced |
| Citigroup Inc | 11,599 | $15.0K | 0.00% | +11,599 | New |
| HSBC Holdings PLC | 12,886 | $17.0K | 0.00% | −152−1.2% | Reduced |
| Virtu Financial LLC | 14,491 | $19.0K | 0.00% | +2,030+16.3% | Added |
| Citadel Advisors LLC | 15,930 | $21.0K | 0.00% | −122,654−88.5% | Reduced |
| Millennium Management LLC | 18,530 | $24.0K | 0.00% | −38,051−67.3% | Reduced |
| Northern Trust Corp | 18,175 | $24.0K | 0.00% | 00.0% | Unchanged |
| Raymond James Financial Services Advisors, Inc. | 22,311 | $29.0K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 28,764 | $37.0K | 0.00% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 30,278 | $39.0K | 0.00% | −29,546−49.4% | Reduced |
| BIT Capital GmbH | 30,000 | $39.0K | 0.01% | −20,000−40.0% | Reduced |
| Crestline Management, LP | 34,305 | $45.0K | 0.01% | −444−1.3% | Reduced |
| Two Sigma Advisers, LP | 50,900 | $66.0K | 0.00% | −99,200−66.1% | Reduced |
| Two Sigma Investments, LP | 58,325 | $76.0K | 0.00% | −101,373−63.5% | Reduced |
| Geode Capital Management, LLC | 79,364 | $103.0K | 0.00% | 00.0% | Unchanged |
| Ensign Peak Advisors, Inc | 151,777 | $197.0K | 0.00% | +112,002+281.6% | Added |
| Bridgeway Capital Management, LLC | 187,000 | $243.0K | 0.01% | +40,000+27.2% | Added |
| Renaissance Technologies LLC | 242,352 | $315.0K | 0.00% | −196,782−44.8% | Reduced |
| BlackRock Inc. | 314,659 | $410.0K | 0.00% | −6,633−2.1% | Reduced |
| Vanguard Group Inc | 435,974 | $567.0K | 0.00% | −1,409−0.3% | Reduced |
| Nan Fung Group Holdings Ltd | 613,223 | $797.0K | 0.55% | 00.0% | Unchanged |
| Tekla Capital Management LLC | 898,374 | $1.17M | 0.05% | 00.0% | Unchanged |
| Blackstone Group Inc. | 1,678,984 | $2.18M | 0.01% | 00.0% | Unchanged |
| Novo Holdings A/S | 2,459,021 | $3.20M | 0.16% | 00.0% | Unchanged |
| Sofinnova Investments, Inc. | 3,083,712 | $4.01M | 0.36% | 00.0% | Unchanged |
| Belvedere Trading LLC | 0 | $0 | 0.00% | −101,413−100.0% | Sold out |
| D. E. Shaw & Co., Inc. | 0 | $0 | 0.00% | −37,693−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −34,353−100.0% | Sold out |
| Occudo Quantitative Strategies LP | 0 | $0 | 0.00% | −30,442−100.0% | Sold out |
| Schonfeld Strategic Advisors LLC | 0 | $0 | 0.00% | −26,600−100.0% | Sold out |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −18,004−100.0% | Sold out |
| Bank of Montreal | 0 | $0 | 0.00% | −5,800−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −6,200−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −1,316−100.0% | Sold out |
| Susquehanna Fundamental Investments, LLC | – | – | – | – | Not filed |